MedTrace Logo

Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion

NCT02304835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 322

Last updated 2014-12-05

No results posted yet for this study

Summary

This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres.

The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.

Conditions

  • Abortion; Attempted, Medical

Sponsors & Collaborators

  • Nordic Pharma SAS

    lead INDUSTRY

Principal Investigators

  • Danielle HASSOUN, MD · Cabinet Médical

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02304835 on ClinicalTrials.gov